Subramanian, S., Rajendiran, M., Paramasivam, M., Murugesan, I., Palani, S., & Velusamy, S. (2026). Advances in SGLT2 Inhibitor Therapy: Comparative Evidence for Empagliflozin and Dapagliflozin in Cardio-Renal-Metabolic Disorders. International Journal of Advancement in Life Sciences Research, 9(4), 56-68. https://doi.org/https://doi.org/10.31632/ijalsr.2026.v09i04.004